InsideTrading SEC Form 4 insider trades

Stocks

LENZ LENZ Therapeutics, Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $129.8M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $2.0M, sold $0 2022-Q2: bought $1.8M, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $0, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $551.0K, sold $0 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $26.4M 2025-Q3: bought $0, sold $40.3M 2025-Q4: bought $289.3K, sold $261.0K 2026-Q1: bought $365.6K, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $9.1M
Bought, above the line (largest quarter $2.0M) Sold, below the line (largest quarter $40.3M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$2.0M$0
2022-Q2$1.8M$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$0$0
2024-Q1$0$0
2024-Q2$551.0K$0
2024-Q3$0$0
2024-Q4$0$0
2025-Q1$0$0
2025-Q2$0$26.4M
2025-Q3$0$40.3M
2025-Q4$289.3K$261.0K
2026-Q1$365.6K$0
2026-Q2$0$0
2026-Q3$0$0
2026-Q4$0$9.1M

Insider activity

Download CSV Up to 5,000 rows
Bought$7.2M16 buy days
Sold$76.0M14 sell days
Net insider flow-$68.8Mnet selling · 5 years
Latest trade2026-10-29RA Capital Healthcare Fund LP
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-10-29 Sell RA Capital Healthcare Fund LP 10% owner 2,718,684 $3.36 $9.1M 3
2026-03-27 Buy Schimmelpennink Evert B. CEO 28,089 $8.95 $251.4K 1
2026-03-27 Buy Chevallard Daniel R. CFO 7,500 $8.57 $64.3K 1
2026-03-27 Buy George Jeffrey P. Director 5,592 $8.92 $49.9K 1
2025-11-17 Sell Olsson Shawn Other C-suite 10,000 $26.10 $261.0K 2
2025-11-07 Buy MCCOLLUM JAMES W Director 10,500 $22.79 $239.3K 1
2025-11-07 Buy Chevallard Daniel R. CFO 2,198 $22.76 $50.0K 2
2025-09-30 Sell Versant Venture Capital VI, L.P. 10% owner 224,974 $46.01 $10.4M 6
2025-09-18 Sell Versant Venture Capital VI, L.P. 10% owner 135,304 $42.23 $5.7M 6
2025-08-26 Sell Versant Venture Capital VI, L.P. 10% owner 70,811 $39.01 $2.8M 4
2025-08-25 Sell Versant Venture Capital VI, L.P. 10% owner 78,237 $39.55 $3.1M 4
2025-08-22 Sell Versant Venture Capital VI, L.P. 10% owner 39,046 $40.15 $1.6M 4
2025-08-18 Sell Versant Venture Capital VI, L.P. 10% owner 45,713 $38.56 $1.8M 2
2025-08-15 Sell Versant Venture Capital VI, L.P. 10% owner 215,000 $39.50 $8.5M 2
2025-07-10 Sell Versant Venture Capital VI, L.P. 10% owner 191,376 $34.00 $6.5M 1
2025-06-27 Sell Versant Venture Capital VI, L.P. 10% owner 200,000 $30.47 $6.1M 1
2025-06-20 Sell Versant Venture Capital VI, L.P. 10% owner 234,801 $30.29 $7.1M 2
2025-06-18 Sell Versant Venture Capital VI, L.P. 10% owner 100,000 $29.95 $3.0M 1
2025-06-10 Sell Versant Venture Capital VI, L.P. 10% owner 350,000 $29.00 $10.2M 1
2024-05-14 Buy Chevallard Daniel R. CFO 3,188 $15.68 $50.0K 1
2024-05-13 Buy MCCOLLUM JAMES W Director 31,332 $15.99 $501.0K 1
2022-04-12 Buy AKKARAJU SRINIVAS 10% owner 350,000 $4.08 $1.4M 1
2022-04-11 Buy AKKARAJU SRINIVAS 10% owner 74,464 $4.07 $303.1K 1
2022-04-11 Buy Gutry Phil Other C-suite 5,000 $4.01 $20.0K 1
2022-01-24 Buy AKKARAJU SRINIVAS 10% owner 23,000 $8.70 $200.1K 1
2022-01-21 Buy AKKARAJU SRINIVAS 10% owner 100,000 $8.99 $899.0K 1
2022-01-20 Buy AKKARAJU SRINIVAS 10% owner 43,105 $8.92 $384.5K 1
2022-01-19 Buy AKKARAJU SRINIVAS 10% owner 54,565 $9.24 $504.2K 1
2021-12-15 Buy AKKARAJU SRINIVAS 10% owner 22,329 $10.19 $227.5K 1
2021-11-22 Buy AKKARAJU SRINIVAS 10% owner 201,685 $10.15 $2.0M 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Versant Venture Capital VI, L.P. 10% owner $0 $66.6M 2025-09-30
RA Capital Healthcare Fund LP 10% owner $0 $9.1M 2026-10-29
AKKARAJU SRINIVAS 10% owner $6.0M $0 2022-04-12
MCCOLLUM JAMES W Director $740.3K $0 2025-11-07
Olsson Shawn Other C-suite $0 $261.0K 2025-11-17
Schimmelpennink Evert B. CEO $251.4K $0 2026-03-27
Chevallard Daniel R. CFO $164.3K $0 2026-03-27
George Jeffrey P. Director $49.9K $0 2026-03-27
Gutry Phil Other C-suite $20.0K $0 2022-04-11

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2026-03-27 3 $365.6K 57 -10.3% (+0.6% raw)-59.6% (-36.9% raw)-71.4% (-57.1% raw) closed
2021-06-29 4 $14.7M 44 -26.7% (-24.5% raw)-40.0% (-39.1% raw)-65.5% (-54.7% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.